SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brent who wrote (21029)4/21/1999 5:57:00 PM
From: VLAD  Read Replies (1) of 23519
 
Brent,

I think you should sell your stock tomorrow.

Call me the eternal optimist but I perceive Vivus as a small cap biotech company whose ultimate success will be dependent on the R&D front. And I like what I'm hearing.

Do you remember the short's "one trick pony" trick?

That all looks to me to be rapidly changing. Look at the R&D front now:

1)Alibra finishing up phase III now.
2)A new premature ejaculation product going into phase II later this year. This proves to the Street that the premature ejaculation talk was not just talk/fluff and there is a REAL product with HUGE potential that Vivus is working on.
3)Dr. Christ's gene therapy work continues to progress and IMO will eventually lead to an injectable product to treat organic vascular ED. He is also doing research on gene therapy as it relates to cancer(I need to find out more).
4)Femme Cream product. I'm a little disappointed that they didn't have more to say on the femme cream. As you know the potential is HUGE.

I think that covers everything important on the R&D front. I believe all 4 of these points will result in a marketable product.

The shorts can no longer attempt to instill the fear that Vivus is going Chapter 11. What a crock! Vivus is sitting on $36M cash and current product sales of MUSE will cover expenses.

If Vivus announces a domestic partner deal in 2 weeks we can easily be looking at a $20/share stock.

Remember....THIS IS NOT AN INTERNUT STOCK!!!!

VLAD

PS I still think Leland needs to take a hike!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News